v3.26.1
Stock-Based Compensation - Non-options (Details) - USD ($)
1 Months Ended 12 Months Ended
Apr. 08, 2025
Jun. 30, 2025
Jul. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Weighted average price          
Share-based compensation costs       $ 2,767,000 $ 6,156,000
BTI RSU          
Number of shares          
Outstanding, beginning balance (in shares)       27,000  
Granted (in shares) 66,000     111,000  
Vested (in shares)       (24,000)  
Cancelled (in shares)       (7,000)  
Outstanding, ending balance (in shares)       107,000 27,000
Weighted average price          
Vesting period 1 year        
Unrecognized stock-based compensation expense       $ 198,000 $ 760,000
Fair value, non-option       $ 50,000  
BTI RSU | RSU vesting 25% at one year and remaining in 12 quarters          
Weighted average price          
Vesting period       4 years  
Vesting (as a percent)       25.00%  
BTI RSU | Employee          
Weighted average price          
Granted, Weighted average price (in dollars per share)       $ 1.65  
Vesting period       1 year  
BTI RSU | Executive officers          
Weighted average price          
Vesting period       9 months  
BTI PSU          
Number of shares          
Outstanding, beginning balance (in shares)       70,000  
Granted (in shares)     87,000 0  
Vested (in shares)       (57,000)  
Cancelled (in shares)       (13,000)  
Outstanding, ending balance (in shares)       0 70,000
Weighted average price          
Granted, Weighted average price (in dollars per share)     $ 19.2    
Vesting period     1 year    
Unrecognized stock-based compensation expense       $ 0  
Share-based compensation costs   $ 1,098,000      
Fair value, non-option       $ 103,000  
OnkosXcel PSU          
Number of shares          
Outstanding, beginning balance (in shares)       1,166,000  
Granted (in shares)       0 15
Cancelled (in shares)       (94,000)  
Forfeited (in shares)       0  
Outstanding, ending balance (in shares)       1,072,000 1,166,000
Vested aggregate (in shares)       1,021,000  
Weighted average price          
Outstanding, Weighted average price beginning balance (in dollars per share)       $ 5,686  
Granted, Weighted average price (in dollars per share)       0  
Cancelled, Weighted average price (in dollars per share)       5,953  
Forfeited, Weighted average price (in dollars per share)       0  
Vested, Weighted average price (in dollars per share)       $ 5,602  
Outstanding, Weighted average price ending balance (in dollars per share)         $ 5,686
Vesting period         48 months
Unrecognized stock-based compensation expense       $ 75,000 $ 377,000
OnkosXcel RSUs          
Number of shares          
Outstanding, beginning balance (in shares)       176,000  
Vested (in shares)       (7,000)  
Cancelled (in shares)       (34,000)  
Outstanding, ending balance (in shares)       135,000 176,000
Weighted average price          
Unrecognized stock-based compensation expense       $ 20,000 $ 210,000